CBL.AX
Price:
$0.074
Market Cap:
$24.89M
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a device to control a range of devices, including wheelchairs, dining robots, and gaming systems; Uno Touch, a speech generating device; and other sensors for multiple applications. The company was formerly known as Control...[Read more]
Industry
Medical - Devices
IPO Date
2020-12-06
Stock Exchange
ASX
Ticker
CBL.AX
According to Control Bionics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -3.70. This represents a change of 369.94% compared to the average of -0.79 of the last 4 quarters.
The mean historical PE Ratio of Control Bionics Limited over the last ten years is -25.87. The current -3.70 PE Ratio has changed 1.33% with respect to the historical average. Over the past ten years (40 quarters), CBL.AX's PE Ratio was at its highest in in the December 2015 quarter at 8.49. The PE Ratio was at its lowest in in the December 2017 quarter at -50.36.
Average
-25.87
Median
-2.27
Minimum
-100.72
Maximum
8.27
Discovering the peaks and valleys of Control Bionics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual PE Ratio = 8.27
Minimum Annual Increase = -1317.62%
Minimum Annual PE Ratio = -100.72
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.30 | -7.46% |
| 2024 | -1.40 | 0.53% |
| 2023 | -1.39 | -55.61% |
| 2022 | -3.14 | -80.79% |
| 2021 | -16.35 | -83.22% |
| 2020 | -97.41 | 92.11% |
| 2019 | -50.70 | -49.66% |
| 2018 | -100.72 | -1317.62% |
| 2016 | 8.27 | 52.82% |
| 2015 | 5.41 | Infinity% |
The current PE Ratio of Control Bionics Limited (CBL.AX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.36
5-year avg
-4.72
10-year avg
-25.87
Control Bionics Limited’s PE Ratio is greater than TruScreen Group Limited (-4.19), less than Chimeric Therapeutics Limited (-0.89), less than Adherium Limited (-0.33), less than Intelicare Holdings Limited (0), less than Neurotech International Limited (-1.68), greater than ImExHS Limited (-3.90), greater than InhaleRx Limited (-3.83), less than Percheron Therapeutics Limited (-0.48), less than Bio-Gene Technology Limited (-2.85), greater than Patrys Limited (-24.77),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.19 | $11.96M | |
| -0.89 | $12.75M | |
| -0.33 | $7.71M | |
| 0 | $10.52M | |
| -1.68 | $17.84M | |
| -3.90 | $17.79M | |
| -3.83 | $5.49M | |
| -0.48 | $7.61M | |
| -2.85 | $7.93M | |
| -24.77 | $11.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Control Bionics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Control Bionics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Control Bionics Limited's PE Ratio?
How is the PE Ratio calculated for Control Bionics Limited (CBL.AX)?
What is the highest PE Ratio for Control Bionics Limited (CBL.AX)?
What is the 3-year average PE Ratio for Control Bionics Limited (CBL.AX)?
What is the 5-year average PE Ratio for Control Bionics Limited (CBL.AX)?
How does the current PE Ratio for Control Bionics Limited (CBL.AX) compare to its historical average?